This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: Agenus Inc., Ligand Pharmaceuticals, Inc.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Veronica Franciszka Ilkow: Innovator in Antibody Development
Introduction
Veronica Franciszka Ilkow is a prominent inventor based in Lexington, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of multispecific antibodies. Her work focuses on innovative solutions for therapeutic applications.
Latest Patents
Veronica holds a patent for "Anti-TIGIT and anti-CD96 antibodies." This patent provides multispecific molecules that specifically bind to CD96 and/or TIGIT, along with isolated antibodies that target these proteins. The patent also includes pharmaceutical compositions comprising these molecules, nucleic acids encoding them, expression vectors, and host cells for their production. Furthermore, it outlines methods for treating subjects using these innovative antibodies.
Career Highlights
Veronica is currently associated with Agenus Inc., where she continues to advance her research in antibody development. Her work has the potential to impact various therapeutic areas, particularly in immunotherapy.
Collaborations
Some of her notable coworkers include Dhan Sidhartha Chand and Zahra Jawad, who contribute to her research endeavors at Agenus Inc.
Conclusion
Veronica Franciszka Ilkow is a trailblazer in the field of antibody research, with her innovative patent paving the way for future therapeutic advancements. Her contributions are vital to the ongoing development of effective treatments in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile